Skip to main content

MoneyWorks4Me

Anlon Healthcare submits analyst meet intimation

18 Mar 2026 Evaluate
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (the Regulation) read with part A of Schedule III of the Regulations, Anlon Healthcare has informed that the Punikumar Rasadia, Chairman and Managing Director of the Company will be interacting with the following Analyst(s)/ Investor(s) on Saturday, March 21, 2026 as per the details enclosed. 

The above information is a part of company’s filings submitted to BSE.
Peers
Company Name CMP
Sun Pharma. Inds. 1905.00
Dr. Reddys Labs. 1385.00
Cipla 1406.00
Lupin 2012.00
Zydus Lifesciences 1213.05
View more..